Abstract:In the above-mentioned article the name and funding number of the last funding project was statet incorrectly. Correct: Cuiying Scientific and Technological Innovation Program of The Second Hospital & Clinical Medical School, Lanzhou University (CY2023-YB-B03) This was corrected in the online version on January 12, 2024. Article published online: 12 January 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Correction: Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer

Corrigendum: Prediction of EGFR Mutation Status Based on 18F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma

Correction: Real-world Management of Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small-cell Lung Cancer in the USA

Correction: Deep learning radiomics of multimodal ultrasound for classifying metastatic cervical lymphadenopathy into primary cancer sites: a feasibility study

Correction: The Ineffectiveness of Osimertinib in Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Lung Adenocarcinoma With Bone Metastasis: A Case Report

Erratum: Commentary: Automated machine learning model development for intracranial aneurysm treatment outcome prediction: A feasibility study

Erratum: Author correction to "The FAPα-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway" [Acta Pharm Sin B 12 (2022) 1288-1304].

Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Corrigendum to 'downregulation of ABLIM3 Confers to the Metastasis of Neuroblastoma Via Regulating the Cell Adhesion Molecules Pathway' [comput. Struct. Biotechnol. J., Vol. 23 (2024) 1547-1561].

Corrigendum: A New Prognostic Risk Score: Based on the Analysis of Autophagy-Related Genes and Renal Cell Carcinoma

Erratum: Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience

Corrigendum: Brain Metastases from Esophageal Squamous Cell Carcinoma: Clinical Characteristics and Prognosis

Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases10 (2023) 1367–1401]

Corrigendum to:"Deep learning based suture training system" [Surgery Open Science 15 (2023) 1-11/1]

Corrigendum: Deep Learning-Enabled Clinically Applicable CT Planbox for Stroke With High Accuracy and Repeatability

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Retracted: The Value of Artificial Intelligence Film Reading System Based on Deep Learning in the Diagnosis of Non-Small-Cell Lung Cancer and the Significance of Efficacy Monitoring: A Retrospective, Clinical, Nonrandomized, Controlled Study

Correction: Prediction of Survival Prognosis of Non-Small Cell Lung Cancer by APE1 Through Regulation of Epithelial-Mesenchymal Transition

Correction to "Enhancing the revelation of key genes and interaction networks in non-small cell lung cancer with major depressive disorder: A bioinformatics analysis"

Author Correction to ‘bioengineered Mir-124-3p Prodrug Selectively Alters the Proteome of Human Carcinoma Cells to Control Multiple Cellular Components and Lung Metastasis in Vivo’ [acta Pharmaceutica Sinica B 11 (2021) 3950–3965]

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma